Related references
Note: Only part of the references are listed.Sulfonylureas and the Risk of Ventricular Arrhythmias Among People with Type 2 Diabetes: A Systematic Review of Observational Studies
Nehal Islam et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study
Kristian B. Filion et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence
Charles E. Leonard et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study
M Gulliford et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2004)